Stay updated on Nivolumab Combo in Advanced Biliary Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Combo in Advanced Biliary Cancer Clinical Trial page.

Latest updates to the Nivolumab Combo in Advanced Biliary Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page revision label was updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check31 days agoChange DetectedThe page now displays Revision: v3.4.2, replacing the previous Revision: v3.4.1; this appears to be a minor site version update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check38 days agoChange DetectedRevision: v3.4.1 replaces v3.4.0 on the page, reflecting a minor internal update. This change does not affect the study content, eligibility criteria, contacts, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check52 days agoChange DetectedThe page now includes a Show glossary option and minor label updates (e.g., 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data') with the revision labeled as v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check59 days agoChange DetectedThe page now shows Revision: v3.3.4, replacing Revision: v3.3.3. This appears to be a minor administrative update to the page's revision history and does not alter study content.SummaryDifference0.1%

- Check88 days agoChange DetectedAdded location sections for Georgia, Illinois, Michigan, Pennsylvania, Texas, Washington, and Wisconsin and removed the previous location sections; updated revision to v3.3.3.SummaryDifference0.8%

Stay in the know with updates to Nivolumab Combo in Advanced Biliary Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Combo in Advanced Biliary Cancer Clinical Trial page.